Gyroscope Therapeutics   Report issue

For profit Phase 2
Founded: Stevenage United Kingdom (2017)
Status: Acquired by Novartis (2021)

Organization Overview

First Clinical Trial
2018
NCT03846193
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Gyroscope Therapeutics